Among the participants, 18 patients were previously tested positive for anti‐AGO antibodies, 48 for anti‐FGFR3 antibodies, and 14 had an associated autoimmune disease without detectable anti‐AGO or FGFR3 antibodies. Here, FGFR3 is linked to autoimmune disease.